TrialThe Lancet. Infectious diseases2024

Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trial.

Anne Wajja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.